Latest return on equity
BridgeBio Oncology Therapeutics Return on equity
Direct answer
BridgeBio Oncology Therapeutics's return on equity is -81.92%.
The verified market snapshot reports -81.92%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free BridgeBio Oncology Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -81.92%
Explore related company data
View BridgeBio Oncology Therapeutics's market capitalizationView BridgeBio Oncology Therapeutics's price-to-book ratioView BridgeBio Oncology Therapeutics's dividend yieldView BridgeBio Oncology Therapeutics's 52-week price rangeView BridgeBio Oncology Therapeutics's profit marginView BridgeBio Oncology Therapeutics's debt-to-equity ratioView all BridgeBio Oncology Therapeutics key metricsReturn to BridgeBio Oncology Therapeutics profile